NCT06130722
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06130722
Title First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Suzhou Forlong Biotechnology Co.,Ltd,
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.